Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-09-18 Sale |
2023-09-20 8:06 pm |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
4,359 | $0.69 | $3,008 | 119,153 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-17 8:08 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
9,703 | $0.78 | $7,568 | 283,685 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-17 8:07 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
7,221 | $0.78 | $5,632 | 250,959 (Direct) |
View |
| 2023-08-16 Sale |
2023-08-17 8:06 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
19,998 | $0.78 | $15,598 | 920,209 (Indirect Direct) |
View |
| 2023-06-14 Sale |
2023-06-15 6:26 pm |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
30,000 | $0.57 | $17,100 | 287,750 (Indirect Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 8:29 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
9,791 | $0.72 | $7,050 | 293,388 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 8:28 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
7,543 | $0.72 | $5,431 | 257,680 (Direct) |
View |
| 2023-05-16 Sale |
2023-05-17 8:27 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
20,361 | $0.72 | $14,660 | 940,207 (Indirect Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 9:00 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
10,484 | $3 | $31,452 | 303,179 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 8:59 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
8,275 | $3 | $24,825 | 265,223 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 8:58 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. Chief Financial Officer |
10,267 | $3 | $30,801 | 313,497 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-17 8:57 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
19,635 | $3 | $58,905 | 960,568 (Indirect Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 6:05 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
13,460 | $3.57 | $48,052 | 313,663 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 6:04 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew Chief Legal Officer |
8,690 | $3.57 | $31,023 | 272,498 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 6:03 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. Chief Financial Officer |
11,095 | $3.57 | $39,609 | 323,764 (Direct) |
View |
| 2022-11-16 Sale |
2022-11-18 6:02 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
38,014 | $3.57 | $135,710 | 980,203 (Indirect Direct) |
View |
| 2022-09-23 Sale |
2022-09-26 7:32 pm |
NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director |
4,198 | $3.16 | $13,266 | 31,777 (Direct) |
View |
| 2022-09-23 Sale |
2022-09-26 7:25 pm |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
4,198 | $3.16 | $13,266 | 38,512 (Direct) |
View |
| 2022-09-22 Sale |
2022-09-26 7:23 pm |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
5,100 | $3.19 | $16,269 | 291,273 (Indirect Direct) |
View |
| 2022-09-13 Sale |
2022-09-14 6:01 pm |
NEKTAR THERAPEUTICS | NKTR | EASTHAM KARIN Director |
21,267 | $3.61 | $76,774 | 13,033 (Direct) |
View |
| 2022-08-18 Sale |
2022-08-19 6:27 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
73,716 | $4.65 | $342,779 | 327,123 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:41 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
10,560 | $4.76 | $50,266 | 670,839 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:40 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
3,189 | $4.76 | $15,180 | 613,063 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:40 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
2,006 | $4.76 | $9,549 | 666,734 (Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:39 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
13,759 | $4.76 | $65,493 | 1,839,467 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 9:40 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
21,673 | $3.95 | $85,608 | 276,399 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 9:38 pm |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
3,136 | $3.95 | $12,387 | 117,939 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 9:36 pm |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
5,841 | $3.95 | $23,072 | 170,427 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 9:35 pm |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
36,529 | $3.95 | $144,290 | 621,351 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 9:33 pm |
NEKTAR THERAPEUTICS | NKTR | NORTHCOTT JOHN SVP & Chief Commercial Officer |
4,592 | $3.95 | $18,138 | 223,210 (Direct) |
View |
| 2022-05-16 Sale |
2022-05-17 9:32 pm |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
17,448 | $3.95 | $68,920 | 312,905 (Direct) |
View |
| 2022-02-16 Sale |
2022-02-18 6:20 pm |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
10,912 | $10.95 | $119,486 | 274,122 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-09-19 Option Award |
2023-09-20 8:06 pm |
N/A 2031-09-18 |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
85,000 | $0 | 119,153 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:49 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | WHITFIELD ROY A Director |
30,600 | $0 | 338,150 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:48 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | GREER R SCOTT Director |
30,600 | $0 | 323,974 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:47 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | EASTHAM KARIN Director |
30,600 | $0 | 43,633 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:46 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | Curet Myriam Director |
30,600 | $0 | 56,375 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:45 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | CHESS ROBERT Director |
30,600 | $0 | 316,773 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:43 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | Brainard Diana Director |
30,600 | $0 | 48,960 (Direct) |
View |
| 2022-09-16 Option Award |
2022-09-20 8:41 pm |
N/A 2030-09-15 |
NEKTAR THERAPEUTICS | NKTR | Ajer Jeffrey Robert Director |
30,600 | $0 | 63,110 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 7:41 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
405,000 | $0 | 670,839 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 7:40 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | Wilson Mark Andrew SVP & General Counsel |
497,813 | $0 | 613,063 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 7:40 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
497,813 | $0 | 666,734 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-17 7:39 pm |
N/A 2030-08-14 |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
1,231,875 | $0 | 1,839,467 (Direct) |
View |
| 2022-05-15 Option Award |
2022-05-17 9:40 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Zalevsky Jonathan Chief R&D Officer |
23,950 | $0 | 276,399 (Direct) |
View |
| 2022-05-15 Option Award |
2022-05-17 9:36 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Thomsen Jillian B. SVP & Chief Accounting Officer |
10,950 | $0 | 170,427 (Direct) |
View |
| 2022-05-15 Option Award |
2022-05-17 9:35 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | ROBIN HOWARD W President & CEO |
68,450 | $0 | 621,351 (Direct) |
View |
| 2022-05-15 Option Award |
2022-05-17 9:32 pm |
N/A N/A |
NEKTAR THERAPEUTICS | NKTR | Labrucherie Gil M SVP, COO & CFO |
28,750 | $0 | 312,905 (Direct) |
View |